Trials / Recruiting
RecruitingNCT06215040
The Treatment Effect for Asymptomatic Common Bile Duct Stone
Multicenter Prospective Study for Efficacy of Asymptomatic Common Bile Duct Stone Treatment
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Kyungpook National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.
Detailed description
There is no conflcts for treatment of symptomatic common bile duct stone. As more imaging examination such as healthy screening, more asymptomatic common bile duct stone patients are found. Current guideline for aymptomatic common bile duct stone is removal using endoscopic retrograde cholangiopancreatography. However, the previous studies that support this guideline included patients who just underwent cholecystectomy and were diagnosed as common bile duct stone. There is no prospective study for identify the treatment effectiveness of common bile duct stone removal in asymptomatic patients who are dignosed in healthy screening. Therefore, we are going to find the effectiveness of common bile duct stone removal by comparing questionnarie before and after removal of common bile duct stone in asymptomatic and incidentally found common bile duct stone patients. In addition, we are going to follow up patients who do not want to undergo common bile duct stone removal and find the rate of cholangitis risk. We also want to identify extact complication rate for endoscopic retrograde pancreatocholangiographic procedures in asymptomatic common bile duct stone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopic retrograde cholangiopancratography | common bile duct stone removal |
Timeline
- Start date
- 2024-01-02
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
- First posted
- 2024-01-22
- Last updated
- 2024-01-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06215040. Inclusion in this directory is not an endorsement.